Literature DB >> 15650773

MyD88-dependent induction of allergic Th2 responses to intranasal antigen.

Damani A Piggott1, Stephanie C Eisenbarth, Lan Xu, Stephanie L Constant, James W Huleatt, Christina A Herrick, Kim Bottomly.   

Abstract

MyD88 is a common Toll-like receptor (TLR) adaptor molecule found to be essential for induction of adaptive Th1 immunity. Conversely, innate control of adaptive Th2 immunity has been shown to occur in a MyD88-independent manner. In this study, we show that MyD88 is an essential innate component in the induction of TLR4-dependent Th2 responses to intranasal antigen; thus we demonstrate what we believe to be a novel role for MyD88 in pulmonary Th2 immunity. Induction of the MyD88-independent type I IFN response to LPS is defective in the pulmonary environment. Moreover, in the absence of MyD88, LPS-induced upregulation of costimulatory molecule expression on pulmonary DCs is defective, in contrast to what has been observed with bone marrow-derived DCs (BMDCs). Reconstitution of Th2 responses occurs upon adoptive pulmonary transfer of activated BMDCs to MyD88-deficient recipients. Furthermore, the dependence of Th2 responses on MyD88 is governed by the initial route of antigen exposure; this demonstrates what we believe are novel site-specific innate mechanisms for control of adaptive Th2 immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650773      PMCID: PMC544038          DOI: 10.1172/JCI22462

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

Review 1.  Control of adaptive immune responses by Toll-like receptors.

Authors:  Gregory M Barton; Ruslan Medzhitov
Journal:  Curr Opin Immunol       Date:  2002-06       Impact factor: 7.486

2.  Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ.

Authors:  Stephanie L Constant; Jennifer L Brogdon; Damani A Piggott; Christina A Herrick; Irene Visintin; Nancy H Ruddle; Kim Bottomly
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 3.  TIR domain-containing adaptors define the specificity of TLR signaling.

Authors:  Masahiro Yamamoto; Kiyoshi Takeda; Shizuo Akira
Journal:  Mol Immunol       Date:  2004-02       Impact factor: 4.407

4.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

5.  Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.

Authors:  Eric Muraille; Carl De Trez; Maryse Brait; Patrick De Baetselier; Oberdan Leo; Yves Carlier
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

6.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

7.  Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells.

Authors:  Karim Dabbagh; Martin E Dahl; Pamela Stepick-Biek; David B Lewis
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.

Authors:  Tsuneyasu Kaisho; Katsuaki Hoshino; Tomio Iwabe; Osamu Takeuchi; Teruhito Yasui; Shizuo Akira
Journal:  Int Immunol       Date:  2002-07       Impact factor: 4.823

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen.

Authors:  Stephanie C Eisenbarth; Damani A Piggott; James W Huleatt; Irene Visintin; Christina A Herrick; Kim Bottomly
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

View more
  78 in total

Review 1.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

Review 2.  Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.

Authors:  M Goldman
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 3.  Structural biology of allergens.

Authors:  Wayne R Thomas; Belinda J Hales; Wendy-Anne Smith
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.806

Review 4.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  The novel structure of the cockroach allergen Bla g 1 has implications for allergenicity and exposure assessment.

Authors:  Geoffrey A Mueller; Lars C Pedersen; Fred B Lih; Jill Glesner; Andrea F Moon; Martin D Chapman; Kenneth B Tomer; Robert E London; Anna Pomés
Journal:  J Allergy Clin Immunol       Date:  2013-07-31       Impact factor: 10.793

Review 6.  Chemokines and their receptors in the allergic airway inflammatory process.

Authors:  Juan Raymundo Velazquez; Luis Manuel Teran
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

7.  Pulmonary CD103(+) dendritic cells prime Th2 responses to inhaled allergens.

Authors:  H Nakano; M E Free; G S Whitehead; S Maruoka; R H Wilson; K Nakano; D N Cook
Journal:  Mucosal Immunol       Date:  2011-10-19       Impact factor: 7.313

8.  Antigen and lipopolysaccharide play synergistic roles in the effector phase of airway inflammation in mice.

Authors:  Yong Woo Jung; Trenton R Schoeb; Casey T Weaver; David D Chaplin
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  Inhibition of Th2 adaptive immune responses and pulmonary inflammation by leukocyte Ig-like receptor B4 on dendritic cells.

Authors:  Rebecca G Breslow; Jayanti J Rao; Wei Xing; David I Hong; Nora A Barrett; Howard R Katz
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

10.  A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.

Authors:  Anna M Dittrich; Hui-Chen Chen; Lan Xu; Patricia Ranney; Sean Connolly; Timur O Yarovinsky; H Kim Bottomly
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.